We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Packaging regulations: environmental requirements, recycling
Evaluations made by the Rapid Review Panel (RRP) on submitted products.
Work out the VAT liability of goods and services supplied by health and care institutions and providers of non residential care to children.
A range of tests are available from the majority of PHE regional clinical microbiology laboratories.
Tools and resources for commissioners of HIV, sexual and reproductive health services to help plan and commission regional and local services.
Check the tariff classification for preparations put up for retail sale.
This report explains the implications and benefits of an integrated approach to hospital cleaning which utilises a combination of microfibre cleaning materials and periodic steam cleaning.
Check the tariff classification for various types of shelves suitable for use in the bathroom, shower or entrance hall.
Product Safety Report for Stay Young Face & Body Cream sold via eBay presenting a serious chemical risk.
Detailed information on different areas of health protection.
This series aims to share the expertise gained under the Government Chemist function, particularly during referee analysis.
National Patient Safety Alerts (NatPSAs) are official notices giving instructions to NHS bodies on how to prevent risks which might cause serious harm or death.
The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion)
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).